Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-25T17:17:23.679Z Has data issue: false hasContentIssue false
  • English
  • Français

Lost in Translation

Published online by Cambridge University Press:  21 June 2016

Nasia Safdar  and
Dennis G. Maki
Nasia Safdar
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin
Dennis G. Maki*
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin
*
University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792 (dgmaki@medicine.wisc.edu)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 1 , January 2006 , pp. 3 - 7
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

References

1.Arnow, PM, Quimosing, EM, Beach, M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778–784.Google Scholar
2.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994; 271:1598–1601.Google Scholar
3.Collignon, PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374–378.Google Scholar
4.Rello, J, Ochagavia, A, Sabanes, E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027–1030.Google Scholar
5.Smith, RL, Meixler, SM, Simberkoff, MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991; 100:164–167.Google Scholar
6.Warren, DK, Yokoe, DS, Climo, MW, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the Prevention Epicenter Program. Infect Control Hosp Epidemiol 2006; 27:8–13 (in this issue).Google Scholar
7.Braun, BI, Kritchevsky, SB, Kusek, L, et al. Comparing bloodstream infection rates: the effect of indicator specifications in the Evaluation of Processes and Indicators in Infection Control (EPIC) study. Infect Control Hosp Epidemiol 2006; 27:14–22 (in this issue).Google Scholar
8.Maragakis, LL, Bradley, KL, Song, X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27:67–70 (in this issue).CrossRefGoogle ScholarPubMed
9.Menyhay, SZ, Maki, DG. Disinfection of needleless connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic barrier cap. Infect Control Hosp Epidemiol 2006; 27:23–27 (in this issue).Google Scholar
10.Huang, Y-C, Wang, Y-H, Su, L-H, Chou, Y-H, Lien, R-I, Lin, T-Y. Determining the significance of coagulase-negative staphylococci identified in cultures of paired blood specimens from neonates by species identification and strain clonality. Infect Control Hosp Epidemiol 2006; 27:70–73 (in this issue).Google Scholar
11.Raad, II, Hohn, DC, Gilbreath, BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231–238.CrossRefGoogle ScholarPubMed
12.Chaiyakunapruk, N, Veenstra, DL, Lipsky, BA, Saint, S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792–801.Google Scholar
13.Berenholtz, SM, Pronovost, PJ. Barriers to translating evidence into practice. Curr Opin Crit Care 2003; 9:321–325.Google Scholar
14.Maue, SK, Segal, R, Kimberlin, CL, Lipowski, EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. Am J Manag Care 2004; 10:383–391.Google Scholar
15.Cabana, MD, Rand, CS, Powe, NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458–1465.Google Scholar
16.Pathman, DE, Konrad, TR, Freed, GL, Freeman, VA, Koch, GG. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care 1996; 34:873–889.CrossRefGoogle ScholarPubMed
17.Davis, DA, Thomson, MA, Oxman, AD, Haynes, RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274:700–705.Google Scholar
18.O'Grady, NP, Alexander, M, Dellinger, EP, et al. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51(RR-10):1–29.Google Scholar
18a.Pearson, ML. Guideline for the prevention of intravascular-device–related infections, Part I. Intravascular-device–related infections: an overview. Infect Control Hosp Epidemiol 1996; 24:262–277.Google Scholar
19.Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Bundle for prevention of intravascular device–related bloodstream infections. Available at http://www.jcaho.org/. Accessed November 27, 2005.Google Scholar
20. Institute of Healthcare Improvement (IHI) “Save 100,000 Lives” campaign. IHI Web site. Available at http://www.ihi.org/IHI/Programs/Campaign/. Accessed November 27, 2005.Google Scholar
21.Rubinson, L, Wu, AW, Haponik, EF, Diette, GB. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol 2005; 26:525–533.Google Scholar
22.Berenholtz, SM, Pronovost, PJ, Lipsett, PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014–2020.Google Scholar
23.McKibben, L, Horan, T, Tokars, JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005; 33:217–226.Google Scholar
24.Mendelson, MH, Short, LJ, Schechter, CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol 1998; 19:401–406.Google Scholar
25.Lawrence, LW, Delclos, GL, Felknor, SA, et al. The effectiveness of a needleless intravenous connection system: an assessment by injury rate and user satisfaction. Infect Control Hosp Epidemiol 1997; 18:175–182.Google Scholar
26.Skolnick, R, LaRocca, J, Barba, D, Paicius, L. Evaluation and implementation of a needleless intravenous system: making needlesticks a needless problem. Am J Infect Control 1993; 21:39–41.Google Scholar
27.Gartner, K. Impact of a needleless intravenous system in a university hospital. J Healthc Mater Manage 1993; 11:44-46, 48–49.Google Scholar
28.Do, AN, Ray, BJ, Banerjee, SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179:442–448.Google Scholar
29.McDonald, LC, Banerjee, SN, Jarvis, WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol 1998; 19:772–777.Google Scholar
30.Cookson, ST, Ihrig, M, O'Mara, EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998; 19:23–27.Google Scholar
31.Kellerman, S, Shay, DK, Howard, J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996; 129:711–717.Google Scholar
32.Danzig, LE, Short, LJ, Collins, K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995; 273:1862–1864.Google Scholar
33.Yebenes, JC, Vidaur, L, Serra-Prat, M, et al. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control 2004; 32:291–295.CrossRefGoogle ScholarPubMed
34.Inoue, Y, Nezu, R, Matsuda, H, et al. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. JPEN J Patenter Enteral Nutr 1992; 16:581–585.Google Scholar
35.Halpin, DP, O'Byrne, P, McEntee, G, Hennessy, TP, Stephens, RB. Effect of a betadine connection shield on central venous catheter sepsis. Nutrition 1991; 7:33–34.Google ScholarPubMed
36.Inoue, Y, Nezu, R, Matsuda, H, et al. Experimental study of hub contamination: effect of a new connection device: the I system. JPEN J Patenter Enteral Nutr 1992; 16:178–180.Google Scholar
37.Stotter, AT, Ward, H, Waterfield, AH, Hilton, J, Sim, AJ. Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN J Parenter Enteral Nutr 1987; 11:159–162.Google Scholar
38.Souvenir, D, Anderson, DE Jr., Palpant, S, et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998; 36:1923–1926.Google Scholar
39.Mutnick, AH, Kirby, JT, Jones, RN. CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance. Ann Pharmacother 2003; 37:47–56.Google Scholar
40.Kloos, WE, Bannerman, TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994; 7:117–140.Google Scholar
41.Thylefors, JD, Harbarth, S, Pittet, D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 1998; 19:581–589.Google Scholar
42.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887–892.Google Scholar
43.Frebourg, NB, Lefebvre, S, Baert, S, Lemeland, JF. PCR-based assay for discrimination between invasive and contaminating Staphylococcus epi-dermidis strains. J Clin Microbiol 2000; 38:877–880.Google Scholar
44.Rohde, H, Kalitzky, M, Kroger, N, et al. Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit. J Clin Microbiol 2004; 42:5614–5619.Google Scholar
45.Vandecasteele, SJ, Peetermans, WE, R, RM, Rijnders, BJ, Van Eldere, J. Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 2003; 9:114–119.Google Scholar
46.Galdbart, JO, Allignet, J, Tung, HS, Ryden, C, El Solh, N. Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses. J Infect Dis 2000; 182:351–355.Google Scholar
47.Haimi-Cohen, Y, Shafinoori, S, Tucci, V, Rubin, LG. Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures. Pediatr Infect Dis J 2003; 22:968–974.Google Scholar
48.Seo, SK, Venkataraman, L, DeGirolami, PC, Samore, MH. Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med 2000; 109:697–704.Google Scholar
49.Tokars, JI. Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance. Clin Infect Dis 2004;39:333–341.CrossRefGoogle ScholarPubMed
50.Mahieu, LM, De Dooy, JJ, Cossey, VR, et al. Internal and external validation of the NOSEP prediction score for nosocomial sepsis in neonates. Crit Care Med 2002; 30:1459–1466.Google Scholar
51.Calfee, DP, Farr, BM. Comparison of four antiseptic preparations for skin in the prevention of contamination of percutaneously drawn blood cultures: a randomized trial. J Clin Microbiol 2002; 40:1660–1665.Google Scholar
52.Champagne, S, Fussell, S, Scheifele, D. Evaluation of skin antisepsis prior to blood culture in neonates. Infect Control 1984; 5:489–491.Google Scholar
53.Little, JR, Murray, PR, Traynor, PS, Spitznagel, E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med 1999; 107:119–125.Google Scholar
54.Trautner, BW, Clarridge, JE, Darouiche, RO. Skin antisepsis kits containing alcohol and chlorhexidine gluconate or tincture of iodine are associated with low rates of blood culture contamination. Infect Control Hosp Epidemiol 2002; 23:397–401.Google Scholar
55.Strand, CL, Wajsbort, RR, Sturmann, K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA 1993; 269:1004–1006.Google Scholar
56.Surdulescu, S, Utamsingh, D, Shekar, R. Phlebotomy teams reduce blood-culture contamination rate and save money. Clin Perform Qual Health Care 1998; 6:60–62.Google Scholar
57.Gibb, AP, Hill, B, Chorel, B, Brant, R. Reduction in blood culture contamination rate by feedback to phlebotomists. Arch Pathol Lab Med 1997; 121:503–507.Google Scholar
58.Weinbaum, FI, Lavie, S, Danek, M, Sixsmith, D, Heinrich, GF, Mills, SS. Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol 1997; 35:563–565.Google Scholar